935 related articles for article (PubMed ID: 9270635)
1. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation.
Kroshus TJ; Kshettry VR; Savik K; John R; Hertz MI; Bolman RM
J Thorac Cardiovasc Surg; 1997 Aug; 114(2):195-202. PubMed ID: 9270635
[TBL] [Abstract][Full Text] [Related]
2. Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome.
Smith MA; Sundaresan S; Mohanakumar T; Trulock EP; Lynch JP; Phelan DL; Cooper JD; Patterson GA
J Thorac Cardiovasc Surg; 1998 Nov; 116(5):812-20. PubMed ID: 9806388
[TBL] [Abstract][Full Text] [Related]
3. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome.
Daud SA; Yusen RD; Meyers BF; Chakinala MM; Walter MJ; Aloush AA; Patterson GA; Trulock EP; Hachem RR
Am J Respir Crit Care Med; 2007 Mar; 175(5):507-13. PubMed ID: 17158279
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for the development of obliterative bronchiolitis after lung transplantation.
Girgis RE; Tu I; Berry GJ; Reichenspurner H; Valentine VG; Conte JV; Ting A; Johnstone I; Miller J; Robbins RC; Reitz BA; Theodore J
J Heart Lung Transplant; 1996 Dec; 15(12):1200-8. PubMed ID: 8981205
[TBL] [Abstract][Full Text] [Related]
5. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.
Heng D; Sharples LD; McNeil K; Stewart S; Wreghitt T; Wallwork J
J Heart Lung Transplant; 1998 Dec; 17(12):1255-63. PubMed ID: 9883768
[TBL] [Abstract][Full Text] [Related]
6. Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation.
Ailawadi G; Smith PW; Oka T; Wang H; Kozower BD; Daniel TM; Kron IL; Jones DR
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):594-602. PubMed ID: 18329476
[TBL] [Abstract][Full Text] [Related]
7. Obliterative bronchiolitis after lung and heart-lung transplantation. An analysis of risk factors and management.
Bando K; Paradis IL; Similo S; Konishi H; Komatsu K; Zullo TG; Yousem SA; Close JM; Zeevi A; Duquesnoy RJ
J Thorac Cardiovasc Surg; 1995 Jul; 110(1):4-13; discussion 13-4. PubMed ID: 7609567
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus pneumonitis is a risk for bronchiolitis obliterans syndrome in lung transplantation.
Snyder LD; Finlen-Copeland CA; Turbyfill WJ; Howell D; Willner DA; Palmer SM
Am J Respir Crit Care Med; 2010 Jun; 181(12):1391-6. PubMed ID: 20167845
[TBL] [Abstract][Full Text] [Related]
9. Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome.
Valentine VG; Gupta MR; Walker JE; Seoane L; Bonvillain RW; Lombard GA; Weill D; Dhillon GS
J Heart Lung Transplant; 2009 Feb; 28(2):163-9. PubMed ID: 19201342
[TBL] [Abstract][Full Text] [Related]
10. Influence of donor and recipient HLA locus mismatching on development of obliterative bronchiolitis after lung transplantation.
Schulman LL; Weinberg AD; McGregor CC; Suciu-Foca NM; Itescu S
Am J Respir Crit Care Med; 2001 Feb; 163(2):437-42. PubMed ID: 11179119
[TBL] [Abstract][Full Text] [Related]
11. Critical issues in pediatric lung transplantation.
Armitage JM; Kurland G; Michaels M; Cipriani LA; Griffith BP; Fricker FJ
J Thorac Cardiovasc Surg; 1995 Jan; 109(1):60-4; discussion 64-5. PubMed ID: 7815808
[TBL] [Abstract][Full Text] [Related]
12. Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation.
Glanville AR; Aboyoun CL; Havryk A; Plit M; Rainer S; Malouf MA
Am J Respir Crit Care Med; 2008 May; 177(9):1033-40. PubMed ID: 18263803
[TBL] [Abstract][Full Text] [Related]
13. Delayed development of obliterative bronchiolitis syndrome with OKT3 after unilateral lung transplantation. A plea for multicenter immunosuppressive trials.
Ross DJ; Jordan SC; Nathan SD; Kass RM; Koerner SK
Chest; 1996 Apr; 109(4):870-3. PubMed ID: 8635362
[TBL] [Abstract][Full Text] [Related]
14. Detection of Epstein-Barr virus DNA in peripheral blood is associated with the development of bronchiolitis obliterans syndrome after lung transplantation.
Engelmann I; Welte T; Fühner T; Simon AR; Mattner F; Hoy L; Schulz TF; Gottlieb J
J Clin Virol; 2009 May; 45(1):47-53. PubMed ID: 19303808
[TBL] [Abstract][Full Text] [Related]
15. Impact of ganciclovir prophylaxis on heart-lung and lung transplant recipients.
Soghikian MV; Valentine VG; Berry GJ; Patel HR; Robbins RC; Theodore J
J Heart Lung Transplant; 1996 Sep; 15(9):881-7. PubMed ID: 8889983
[TBL] [Abstract][Full Text] [Related]
16. Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis.
Valentine VG; Robbins RC; Berry GJ; Patel HR; Reichenspurner H; Reitz BA; Theodore J
J Heart Lung Transplant; 1996 Apr; 15(4):371-83. PubMed ID: 8732596
[TBL] [Abstract][Full Text] [Related]
17. Does bronchial artery revascularization influence results concerning bronchiolitis obliterans syndrome and/or obliterative bronchiolitis after lung transplantation?
Nørgaard MA; Andersen CB; Pettersson G
Eur J Cardiothorac Surg; 1998 Sep; 14(3):311-8. PubMed ID: 9761443
[TBL] [Abstract][Full Text] [Related]
18. Improved long-term graft outcome in lung transplant recipients who have donor antigen-specific hyporeactivity.
Reinsmoen NL; Bolman RM; Savik K; Butters K; Matas AJ; Hertz MI
J Heart Lung Transplant; 1994; 13(1 Pt 1):30-6; discussion 36-7. PubMed ID: 7513186
[TBL] [Abstract][Full Text] [Related]
19. Analysis of time-dependent risks for infection, rejection, and death after pulmonary transplantation.
Bando K; Paradis IL; Komatsu K; Konishi H; Matsushima M; Keena RJ; Hardesty RL; Armitage JM; Griffith BP
J Thorac Cardiovasc Surg; 1995 Jan; 109(1):49-57; discussion 57-9. PubMed ID: 7815807
[TBL] [Abstract][Full Text] [Related]
20. Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation.
Lobo LJ; Aris RM; Schmitz J; Neuringer IP
J Heart Lung Transplant; 2013 Jan; 32(1):70-7. PubMed ID: 23260706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
